1.0Arthritis Australiahttps://old.arthritisaustralia.org.au/wordpressarthritishttps://old.arthritisaustralia.org.au/wordpress/author/arthritis/Secukinumabrich600338<blockquote class="wp-embedded-content" data-secret="CgCDoKTHwZ"><a href="https://old.arthritisaustralia.org.au/wordpress/medication-search/secukinumab/">Secukinumab</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://old.arthritisaustralia.org.au/wordpress/medication-search/secukinumab/embed/#?secret=CgCDoKTHwZ" width="600" height="338" title="“Secukinumab” — Arthritis Australia" data-secret="CgCDoKTHwZ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://old.arthritisaustralia.org.au/wordpress/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
Secukinumab (brand name: Cosentyx(r)) is a medicine used to treat adults with psoriatic arthritis, an inflammatory disease of the joints that is often accompanied by psoriasis. Secukinumab is also used to treat adults with moderate to severe plaque psoriasis that is chronic (lasts for a long time). Secukinumab may also be used to treat adults with ankylosing spondylitis, an inflammatory disease which primarily affects the spine, causing inflammation and pain in the spinal joints.https://old.arthritisaustralia.org.au/wordpress/wp-content/uploads/2018/05/Arthritis-Logo.jpg1275404